한글목차

의약품 중간체 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 349억 5,000만 달러에서 2026년에는 373억 8,000만 달러에 이르고, CAGR 7.0%로 성장할 전망입니다. 지난 수년간의 성장은 의약품 생산능력 확대, 제네릭 의약품 시장 성장, 원료의약품 중간체 수요 증가, 화학합성에 대한 투자 증가, 숙련된 화학 제조 인력 확보 등이 주요 요인으로 꼽힙니다.

의약품 중간체 시장 규모는 향후 몇 년간에 강력한 성장이 전망됩니다. 2030년에는 495억 2,000만 달러에 이르고, CAGR은 7.3%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 복잡한 의약품 분자 개발 증가, 위탁생산 서비스 수요 증가, 바이오 의약품 파이프라인 확대, 지속 가능한 합성 경로에 대한 집중 강화, 첨단 공정 기술 채택 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 고순도 의약품 중간체 수요 증가, 중간체 제조 아웃소싱 확대, 제네릭 의약품 생산 확대, 특수 화학 중간체 사용 증가, 공정 최적화 및 수율 개선에 대한 집중 등이 있습니다.

의약품 생산량 증가는 향후 의약품 중간체 시장의 성장을 견인할 것으로 예측됩니다. 의약품 생산은 의약물질, 약품 또는 의약품을 제조하는 과정을 말합니다. 의약품은 복잡한 분자구조를 가지고 있으며, 그 합성에는 여러 공정이 필요합니다. 의약품 중간체란 이 제조 공정의 중간 공정에서 생성되는 화합물을 말합니다. 더 복잡하고 표적화된 의약품이 개발됨에 따라 중간체에 대한 수요가 증가하고 있습니다. 예를 들어, 2023년 11월 유럽제약협회(EFPIA)에 따르면, 유럽 제약업계를 대표하는 벨기에 소재 산업단체인 EFPIA에 따르면, 2023년 유럽의 의약품 총 생산액은 3,900억 유로(4,228억 300만 달러)로 2022년 3,633억 유로(3,938억 5,700만 달러)보다 증가할 것으로 예상했습니다. 억 유로(3,938억 5,700만 달러)에서 증가했습니다. 따라서 의약품 생산 증가가 의약품 중간체 시장의 성장을 주도하고 있습니다.

의약품 중간체 시장에서 사업을 전개하는 주요 기업들은 수익성 향상을 위해 API 중간체 등 신제품 라인 개발을 추진하고 있습니다. API 중간체란 의약품 유효성분(API)의 합성에 사용되는 화합물입니다. 예를 들어, 2023년 10월 중국 제약회사 화텅제약(Huateng Pharmaceutical Co., Ltd.)은 소화기 API 중간체 제품 라인을 발표했습니다. 이들 중간체는 소화기 의약품에 함유된 의약품 유효성분의 구성성분으로 작용합니다. 이들은 완하제, 5-HT3 수용체 길항제, H2 수용체 길항제, 양성자 펌프 억제제 등 위장 장애를 치료하는 의약품 제조에 필수적입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharmaceutical intermediates are chemical compounds or substances used in the synthesis and production of active pharmaceutical ingredients (APIs) or drug substances. These intermediates play a crucial role in the development and production of a wide range of drugs and therapeutic products, and they are utilized by pharmaceutical companies and research institutions.

The main types of pharmaceutical intermediates products include chemical intermediates, bulk drug intermediates, and other products. Chemical intermediates are compounds or substances produced during the manufacturing process of chemicals and find applications in various industries, including pharmaceuticals, agrochemicals, polymers, and specialty chemicals. Categories of pharmaceutical intermediates include branded drug intermediates and generic drug intermediates. The applications of pharmaceutical intermediates cover various drugs such as analgesics, anti-infective drugs, cardiovascular drugs, oral antidiabetic drugs, antimicrobial drugs, and others. The end-users of pharmaceutical intermediates include biotech and pharma companies, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the pharmaceutical intermediates market by increasing costs of imported raw chemicals, solvents, catalysts, and specialized manufacturing equipment. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported intermediates, while Asia-Pacific faces pricing pressure on export-driven production. These tariffs are influencing supply chain strategies and cost structures. However, they are also promoting domestic intermediate manufacturing, regional supply diversification, and investments in backward integration.

The pharmaceutical intermediates market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical intermediates market statistics, including pharmaceutical intermediates industry global market size, regional shares, competitors with a pharmaceutical intermediates market share, detailed pharmaceutical intermediates market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical intermediates industry. This pharmaceutical intermediates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical intermediates market size has grown strongly in recent years. It will grow from $34.95 billion in 2025 to $37.38 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to expansion of pharmaceutical manufacturing capacity, growth of generic drug markets, increasing demand for bulk drug intermediates, rising investments in chemical synthesis, availability of skilled chemical manufacturing workforce.

The pharmaceutical intermediates market size is expected to see strong growth in the next few years. It will grow to $49.52 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing development of complex drug molecules, rising demand for contract manufacturing services, expansion of biotech drug pipelines, growing focus on sustainable synthesis routes, increasing adoption of advanced process technologies. Major trends in the forecast period include rising demand for high-purity drug intermediates, increasing outsourcing of intermediate manufacturing, expansion of generic drug production, growing use of specialized chemical intermediates, focus on process optimization and yield improvement.

The increase in pharmaceutical drug production is expected to propel the growth of the pharmaceutical intermediates market going forward. Drug production refers to the process of manufacturing pharmaceutical substances, medications, or drugs. Pharmaceutical drugs are complex molecules that require multiple steps for their synthesis. Pharmaceutical intermediates are chemical compounds produced during these intermediate steps in the manufacturing process. With the development of more complex and targeted drugs, demand for intermediates has grown. For instance, in November 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the rise in pharmaceutical drug production is driving the growth of the pharmaceutical intermediates market.

Major companies operating in the pharmaceutical intermediates market are innovating new product lines, such as API intermediates, to increase their profitability. API intermediates are chemical compounds used in the synthesis of active pharmaceutical ingredients (APIs). For instance, in October 2023, Huateng Pharmaceutical Co. Ltd., a China-based pharmaceutical company, launched its Gastrointestinal API Intermediates product line. These intermediates function as the building blocks for pharmaceutically active ingredients found in digestive system medications. They are essential for producing medications that treat gastrointestinal disorders, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

In March 2024, International Chemical Investors Group (ICIG), a Luxembourg-based chemical company, acquired Vasant Chemicals for an undisclosed sum. This acquisition is designed to strengthen WeylChem's foothold in the global specialty chemicals market. The strategic partnership aims to provide added value for customers and stakeholders by merging the technologies and resources of both companies, thus advancing Vasant Chemicals' global expansion efforts. Vasant Chemicals is an India-based producer of pharmaceutical intermediates.

Major companies operating in the pharmaceutical intermediates market are BASF SE, Lonza Group AG, Evonik Industries AG, LANXESS AG, Arkema S.A., Solvay S.A., Mitsubishi Chemical Group Corporation, Sumitomo Chemical Co., Ltd., Toray Industries, Inc., Asahi Kasei Corporation, Aarti Industries Limited, Divi's Laboratories Limited, PI Industries Limited, Jubilant Pharmova Limited, WuXi AppTec Co., Ltd., Cambrex Corporation, Siegfried Holding AG, DSM-Firmenich AG, Clariant AG, Sanofi S.A

North America was the largest region in the pharmaceutical intermediates market in 2025. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical intermediates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pharmaceutical intermediates market consists of sales of intermediates for API synthesis, API precursors, fine chemicals, and specialty chemicals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Intermediates Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical intermediates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical intermediates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical intermediates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products
• 2) By Category: Branded Drug Intermediate; Generic Drug Intermediate
• 3) By Application: Analgesics; Anti-Infective Drugs; Cardiovascular Drugs; Oral Antidiabetic Drugs; Antimicrobial Drugs; Other Applications
• 4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users
• Subsegments:
• 1) By Chemical Intermediates: Key Starting Materials (KSMs); Advanced Intermediates; Chiral Intermediates; Heterocyclic Intermediates; Functionalized Building Blocks
• 2) By Bulk Drug Intermediates: Precursor Intermediates; Advanced Bulk Intermediates; Late-Stage Intermediates; Isolated Reaction Intermediates
• 3) By Other Products: Biopharmaceutical Process Intermediates; Fermentation-Derived Intermediates; Semi-Synthetic Drug Intermediates
• Companies Mentioned: BASF SE; Lonza Group AG; Evonik Industries AG; LANXESS AG; Arkema S.A.; Solvay S.A.; Mitsubishi Chemical Group Corporation; Sumitomo Chemical Co., Ltd.; Toray Industries, Inc.; Asahi Kasei Corporation; Aarti Industries Limited; Divi's Laboratories Limited; PI Industries Limited; Jubilant Pharmova Limited; WuXi AppTec Co., Ltd.; Cambrex Corporation; Siegfried Holding AG; DSM-Firmenich AG; Clariant AG; Sanofi S.A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Intermediates Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical Intermediates Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Intermediates Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical Intermediates Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics And Precision Medicine
  • 4.1.2 Industry 4.0 And Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.4 Sustainability, Climate Tech And Circular Economy
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Demand For High-Purity Drug Intermediates
  • 4.2.2 Increasing Outsourcing Of Intermediate Manufacturing
  • 4.2.3 Expansion Of Generic Drug Production
  • 4.2.4 Growing Use Of Specialized Chemical Intermediates
  • 4.2.5 Focus On Process Optimization And Yield Improvement

5. Pharmaceutical Intermediates Market Analysis Of End Use Industries

• 5.1 Biotech And Pharmaceutical Companies
• 5.2 Contract Manufacturing Organizations
• 5.3 Research Institutions
• 5.4 Generic Drug Manufacturers
• 5.5 Api Producers

6. Pharmaceutical Intermediates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Intermediates Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical Intermediates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical Intermediates Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical Intermediates Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical Intermediates Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Intermediates Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Intermediates Market Segmentation

• 9.1. Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chemical Intermediate, Bulk Drug Intermediate, Other Products
• 9.2. Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Branded Drug Intermediate, Generic Drug Intermediate
• 9.3. Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
• 9.4. Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biotech And Pharma Companies, Research Institutions, Other End-Users
• 9.5. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Chemical Intermediates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Key Starting Materials (KSMs), Advanced Intermediates, Chiral Intermediates, Heterocyclic Intermediates, Functionalized Building Blocks
• 9.6. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Bulk Drug Intermediates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Precursor Intermediates, Advanced Bulk Intermediates, Late-Stage Intermediates, Isolated Reaction Intermediates
• 9.7. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopharmaceutical Process Intermediates, Fermentation-Derived Intermediates, Semi-Synthetic Drug Intermediates

10. Pharmaceutical Intermediates Market Regional And Country Analysis

• 10.1. Global Pharmaceutical Intermediates Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical Intermediates Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Intermediates Market

• 11.1. Asia-Pacific Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Intermediates Market

• 12.1. China Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Intermediates Market

• 13.1. India Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Intermediates Market

• 14.1. Japan Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Intermediates Market

• 15.1. Australia Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Intermediates Market

• 16.1. Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Intermediates Market

• 17.1. South Korea Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Intermediates Market

• 18.1. Taiwan Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Intermediates Market

• 19.1. South East Asia Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Intermediates Market

• 20.1. Western Europe Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Intermediates Market

• 21.1. UK Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Intermediates Market

• 22.1. Germany Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Intermediates Market

• 23.1. France Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Intermediates Market

• 24.1. Italy Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Intermediates Market

• 25.1. Spain Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Intermediates Market

• 26.1. Eastern Europe Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Intermediates Market

• 27.1. Russia Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Intermediates Market

• 28.1. North America Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Intermediates Market

• 29.1. USA Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Intermediates Market

• 30.1. Canada Pharmaceutical Intermediates Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Intermediates Market

• 31.1. South America Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Intermediates Market

• 32.1. Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Intermediates Market

• 33.1. Middle East Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Intermediates Market

• 34.1. Africa Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical Intermediates Market, Segmentation By Product, Segmentation By Category, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Intermediates Market Regulatory and Investment Landscape

36. Pharmaceutical Intermediates Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical Intermediates Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical Intermediates Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical Intermediates Market Company Profiles
  • 36.3.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. LANXESS AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Arkema S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Intermediates Market Other Major And Innovative Companies

• Solvay S.A., Mitsubishi Chemical Group Corporation, Sumitomo Chemical Co., Ltd., Toray Industries, Inc., Asahi Kasei Corporation, Aarti Industries Limited, Divi's Laboratories Limited, PI Industries Limited, Jubilant Pharmova Limited, WuXi AppTec Co., Ltd., Cambrex Corporation, Siegfried Holding AG, DSM-Firmenich AG, Clariant AG, Sanofi S.A

38. Global Pharmaceutical Intermediates Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Intermediates Market

40. Pharmaceutical Intermediates Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical Intermediates Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical Intermediates Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical Intermediates Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer